Skip to main content
EN
Caution:
At present, there are occasional discrepancies in the display of intellectual property rights holders and their representatives. We are working on a solution.
Patent Search
Details
see.ip - Details for MIRIKIZUMAB ZUR BEHANDLUNG VON COLITIS ULCEROSA
Details for 2019722256
Up to date per 11.06.2026
Actions
Copy link to European Patent
Download Registration Print
Details
Details for 2019722256
Title / Product Name
MIRIKIZUMAB ZUR BEHANDLUNG VON COLITIS ULCEROSA
Status
Granted/Registered
Protection Type
European Patent
(AT-) Application Number
2019722256
EP Publication Number
3773715
E-Number
1684467
Language
EN
PCT Number
US19024633
Publication Date
17.02.2021 A
08.05.2024 B1
Registration Date
08.05.2024
AT Publication Date
15.05.2024
Application Date
28.03.2019
Registration Number
-
Priorities
30.03.2018
US
201862650314 P
IPC
A61K 39/395 20060101AFI20230329BHEP
Maximum Duration of Protection
28.03.2039
Owner
Eli Lilly and Company
Lilly Corporate Center
Indianapolis, IN 46285
US
Representative
Representative
Schwarz & Partner Patentanwälte GmbH
Wipplingerstraße 30
1010 Wien
AT
Inventor
CANAVAN, James Benedict
c/o ELI LILLY AND COMPANY P.O. Box 6288
Indianapolis, Indiana 46206-6288
US
FRIEDRICH, Stuart William
c/o ELI LILLY AND COMPANY P.O. Box 6288
Indianapolis, Indiana 46206-6288
US
KRUEGER, Kathryn Ann
c/o ELI LILLY AND COMPANY P.O. Box 6288
Indianapolis, Indiana 46206-6288
US
MILCH, Catherine
c/o ELI LILLY AND COMPANY P.O. Box 6288
Indianapolis, Indiana 46206-6288
US
TUTTLE, Jay Lawrence
c/o ELI LILLY AND COMPANY P.O. Box 6288
Indianapolis, Indiana 46206-6288
US
Information about Fees
Click here to load the fees